EMA/PE/0000226753
Submitted by Anonymous (not verified) on 3 March 2026 - 15:13
EMA/PE/0000226753
Human medicines: highlights of 2022
Submitted by Anonymous (not verified) on 3 March 2026 - 14:58
Human medicines: highlights of 2022
Human medicines highlights 2022
Submitted by Anonymous (not verified) on 3 March 2026 - 14:57
Human medicines highlights 2022
Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 3 March 2026 - 14:50
Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Aqneursa, L-acetylleucine, Date of authorisation: 19/01/2026, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 3 March 2026 - 11:45
Human medicines European public assessment report (EPAR): Aqneursa, L-acetylleucine, Date of authorisation: 19/01/2026, Revision: 1, Status: Authorised
Scientific Explorer - Frequently Asked Questions
Submitted by Anonymous (not verified) on 3 March 2026 - 10:54
Scientific Explorer - Frequently Asked Questions
Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6
Submitted by Anonymous (not verified) on 3 March 2026 - 9:00
Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6
Herbal medicinal product: Hyperici herba, Hypericum perforatum L.,Cimicifuga racemosa (L.) Nutt., F: Assessment finalised
Submitted by Anonymous (not verified) on 2 March 2026 - 16:32
Herbal medicinal product: Hyperici herba, Hypericum perforatum L.,Cimicifuga racemosa (L.) Nutt., F: Assessment finalised
Veterinary medicines European public assessment report (EPAR): Lotilaner / Milbemycin Elanco, lotilaner,milbemycin oxime, Status: Authorised
Submitted by Anonymous (not verified) on 2 March 2026 - 16:22
Veterinary medicines European public assessment report (EPAR): Lotilaner / Milbemycin Elanco, lotilaner,milbemycin oxime, Status: Authorised
Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 47, Status: Authorised
Submitted by Anonymous (not verified) on 2 March 2026 - 15:44
Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 47, Status: Authorised